These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25309513)

  • 1. The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism.
    Tomita T; Hosoda K; Fujikura J; Inagaki N; Nakao K
    Front Endocrinol (Lausanne); 2014; 5():152. PubMed ID: 25309513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion.
    Itoh Y; Hinuma S
    Hepatol Res; 2005 Oct; 33(2):171-3. PubMed ID: 16214394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term in vitro treatment of INS-1 rat pancreatic β-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors.
    Tuo Y; Feng DD; Wang DF; Sun J; Li SB; Chen C
    Clin Exp Pharmacol Physiol; 2012 May; 39(5):423-8. PubMed ID: 22332921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion.
    El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF
    J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
    Mancini AD; Poitout V
    Trends Endocrinol Metab; 2013 Aug; 24(8):398-407. PubMed ID: 23631851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.
    Rani L; Grewal AS; Sharma N; Singh S
    Mini Rev Med Chem; 2021; 21(4):426-470. PubMed ID: 33100202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of GPR40/FFAR1 does not induce diabetes even under insulin resistance condition.
    Matsuda-Nagasumi K; Takami-Esaki R; Iwachidow K; Yasuhara Y; Tanaka H; Ogi K; Nakata M; Yano T; Hinuma S; Taketomi S; Odaka H; Kaisho Y
    Diabetes Obes Metab; 2013 Jun; 15(6):538-45. PubMed ID: 23331570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.
    Agarwal S; Sasane S; Deshmukh P; Rami B; Bandyopadhyay D; Giri P; Giri S; Jain M; Desai RC
    ACS Med Chem Lett; 2016 Dec; 7(12):1134-1138. PubMed ID: 27994752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders.
    Hara T; Hirasawa A; Ichimura A; Kimura I; Tsujimoto G
    J Pharm Sci; 2011 Sep; 100(9):3594-601. PubMed ID: 21618241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
    Itoh Y; Kawamata Y; Harada M; Kobayashi M; Fujii R; Fukusumi S; Ogi K; Hosoya M; Tanaka Y; Uejima H; Tanaka H; Maruyama M; Satoh R; Okubo S; Kizawa H; Komatsu H; Matsumura F; Noguchi Y; Shinohara T; Hinuma S; Fujisawa Y; Fujino M
    Nature; 2003 Mar; 422(6928):173-6. PubMed ID: 12629551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology and therapeutics of the free fatty acid receptor GPR40.
    Huang H; Dai MH; Tao YX
    Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.
    Mancini AD; Bertrand G; Vivot K; Carpentier É; Tremblay C; Ghislain J; Bouvier M; Poitout V
    J Biol Chem; 2015 Aug; 290(34):21131-21140. PubMed ID: 26157145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges.
    Mohammad S
    Curr Drug Targets; 2016; 17(11):1292-300. PubMed ID: 26648068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of free fatty acid receptor 1 expression in pancreatic β-cells in obese type 2 diabetic db/db mice: a potential role of pancreatic and duodenal homeobox factor 1.
    Kohara K; Obata A; Kimura T; Shimoda M; Moriuchi S; Okauchi S; Hirukawa H; Mune T; Kaku K; Kaneto H
    Endocr J; 2019 Jan; 66(1):43-50. PubMed ID: 30333365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of brain n-3 fatty acids-GPR40/FFAR1 signaling in pain].
    Nakamoto K; Tokuyama S
    Nihon Yakurigaku Zasshi; 2018; 151(1):21-26. PubMed ID: 29321392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose-dependent insulin secretion and improves glucose homeostasis in rats.
    Tsuda N; Kawaji A; Sato T; Takagi M; Higashi C; Kato Y; Ogawa K; Naba H; Ohkouchi M; Nakamura M; Hosaka Y; Sakaki J
    Pharmacol Res Perspect; 2017 Aug; 5(4):. PubMed ID: 28805970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
    Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
    J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse.
    Steneberg P; Rubins N; Bartoov-Shifman R; Walker MD; Edlund H
    Cell Metab; 2005 Apr; 1(4):245-58. PubMed ID: 16054069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPR40: a therapeutic target for mediating insulin secretion (review).
    Feng XT; Leng J; Xie Z; Li SL; Zhao W; Tang QL
    Int J Mol Med; 2012 Dec; 30(6):1261-6. PubMed ID: 23023155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats.
    Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.